Annuloplasty for Not-Severe TR in Patients Undergoing MV Repair Versus Mitral Repair Only (NOSTRUM)

Recruiting N/A Interventional Study
Tricuspid Disease Mitral Regurgitation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
142 (estimated)
Sponsor
Ospedale San Raffaele · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The surgical treatment of less than severe (≤2+/4+) functional tricuspid regurgitation (TR) in patient undergoing mitral valve surgery, is still controversial: some observational studies have suggested that performing tricuspid annuloplasty in patients undergoing mitral valve surgery with a dilated tricuspid annulus, and TR≤2+ may provide a clinical benefit, while in other observational studies su…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age \> 18 years; * ability to provide informed consent; * patients scheduled for mitral valve regurgitation * TR ≤ 2+ with annular dilation * Tricuspid diastolic diameter ≥ 40 mm or 21 mm/m2 Exclusion Criteria: * patient's refusal * non-elective cardiac surgery; * organic di…
Contacts

Michele De Bonis, MD,FESC,FAHA

00390226437118

debonis.michele@hsr.it

CONTACT

Cinzia Trumello, MD

00390226437127

trumello.cinzia@hsr.it

CONTACT